NO942680D0 - Fremgangsmåte for å lage universelle donorceller - Google Patents

Fremgangsmåte for å lage universelle donorceller

Info

Publication number
NO942680D0
NO942680D0 NO942680A NO942680A NO942680D0 NO 942680 D0 NO942680 D0 NO 942680D0 NO 942680 A NO942680 A NO 942680A NO 942680 A NO942680 A NO 942680A NO 942680 D0 NO942680 D0 NO 942680D0
Authority
NO
Norway
Prior art keywords
procedure
donor cells
universal donor
making universal
making
Prior art date
Application number
NO942680A
Other languages
English (en)
Other versions
NO942680L (no
Inventor
Tania L Weiss
Marvin R Garovoy
Anthony Hunt
Bing Huey
Schuman Tam
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO942680D0 publication Critical patent/NO942680D0/no
Publication of NO942680L publication Critical patent/NO942680L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/15Nucleic acids forming more than 2 strands, e.g. TFOs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/3212'-O-R Modification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/353Nature of the modification linked to the nucleic acid via an atom other than carbon
    • C12N2310/3535Nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
NO942680A 1992-01-31 1994-07-15 Fremgangsmåte for å lage universelle donorceller NO942680L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83042792A 1992-01-31 1992-01-31
US94486892A 1992-09-14 1992-09-14
PCT/US1993/000797 WO1993014769A1 (en) 1992-01-31 1993-01-29 Method for making universal donor cells

Publications (2)

Publication Number Publication Date
NO942680D0 true NO942680D0 (no) 1994-07-15
NO942680L NO942680L (no) 1994-08-24

Family

ID=27125355

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942680A NO942680L (no) 1992-01-31 1994-07-15 Fremgangsmåte for å lage universelle donorceller

Country Status (9)

Country Link
EP (1) EP0626852A4 (no)
JP (1) JPH07503612A (no)
AU (1) AU3598293A (no)
BR (1) BR9307844A (no)
CA (1) CA2126692A1 (no)
CZ (1) CZ178394A3 (no)
HU (1) HUT67676A (no)
NO (1) NO942680L (no)
WO (1) WO1993014769A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110946A1 (en) 1992-12-09 1994-06-10 Elazar Rabbani Induction of immunocompatibility by nucleic acid
WO1995006744A2 (en) * 1993-09-03 1995-03-09 Chiron Viagene, Inc. Methods of suppressing immune response by gene therapy
CA2158933A1 (en) * 1993-09-03 1995-03-09 John F. Warner Methods of suppressing graft rejection
JPH09503655A (ja) * 1993-09-03 1997-04-15 チロン ビアジーン インコーポレイティド 自己免疫応答の抑制方法
DE10019252A1 (de) * 2000-04-18 2001-10-31 Klaus Karl Degitz Polydesoxyribonukleotide zur Hemmung der ICAM-1-Genexpression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9106746A (pt) * 1990-08-14 1993-07-20 Isis Pharmaceuticals Inc Oligonucleotideo ou analogo de oligonucleotideo e processos para modular a sintese de moleculas de adesao intracelular de adesao intracelular em um animal e para tratar um animal suspeito de ter uma doenca
NZ299210A (en) * 1992-09-02 2000-08-25 Isis Pharmaceuticals Inc Treating diseases characterised by changes in intercellular adhesion molecules using coding sequences hybridizable with those encoding proteins involved in synthesis of such molecules
CA2110946A1 (en) * 1992-12-09 1994-06-10 Elazar Rabbani Induction of immunocompatibility by nucleic acid

Also Published As

Publication number Publication date
HU9402188D0 (en) 1994-09-28
BR9307844A (pt) 1996-01-09
EP0626852A4 (en) 1996-03-20
AU3598293A (en) 1993-09-01
HUT67676A (en) 1995-04-28
CA2126692A1 (en) 1993-08-05
CZ178394A3 (en) 1995-03-15
JPH07503612A (ja) 1995-04-20
NO942680L (no) 1994-08-24
WO1993014769A1 (en) 1993-08-05
EP0626852A1 (en) 1994-12-07

Similar Documents

Publication Publication Date Title
AU569054B2 (en) Naphtha cat refirming
AU620307B3 (en) Azabicyclic heterocyclic compounds
AU2010988A (en) Water absorbent structures
AU6742087A (en) Substituted indoles
AU7949987A (en) Film storage system
AU6989087A (en) Storage system
AU527130B2 (en) Substituted tetrazines
AU8479782A (en) Optically active 1-aromatic-group-substituted-1-alkanones
AU4874379A (en) Surgical endoprotheses
AU7983987A (en) Cache storage priority
AU7263387A (en) Storage system
AU573912B2 (en) Mowing device
NO942680D0 (no) Fremgangsmåte for å lage universelle donorceller
AU1756183A (en) Surgical scrubbing device
AU564496B2 (en) Burrowing device
NL186975C (nl) Hechtmiddelverdeelbak.
AU7611487A (en) Fungicidal n-(2-cyano-2-oximoacetyl)-aminonitriles
AU5609386A (en) Topical agents for inhibiting the melanin generation
AU557188B2 (en) Surgical drainage device
AU8291987A (en) Microbicides
AU538230B2 (en) Articulating device
AU532822B2 (en) Navigational aid
AU598019B2 (en) Fixing device
AU7636487A (en) Harvester for floating matter
AU2222588A (en) Drain protection device